| Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease. | |
| | |
MedLine Citation:
|
PMID: 8280789 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Oxidative modification of lipoproteins may play a crucial role in the pathogenesis of atherosclerosis. This study was designed to examine whether increased lipid peroxides and/or oxidative susceptibility of plasma lipoproteins occur in patients with coronary artery disease. The levels of lipid peroxides, estimated as thiobarbituric acid-reactive substances (TBARS), were significantly greater in the plasma and very low density lipoprotein (VLDL) of symptomatic patients with coronary artery disease than in those of healthy persons, but the TBARS levels of low density lipoprotein (LDL) and high density lipoprotein (HDL) showed insignificant difference between patients and normals. To evaluate the oxidative susceptibility of lipoproteins, we employed in vitro Cu2+ oxidation of lipoproteins monitored by changes in fluorescence, TBARS level, trinitrobenzene sulfonic acid (TNBS) reactivity, apolipoprotein immunoreactivity and agarose gel electrophoretic mobility. While pooled VLDL and LDL of normal controls were oxidized at 5-10 microM Cu2+, pooled VLDL and LDL of patients with coronary artery disease were oxidized at 1-2.5 microM Cu2+, i.e., at relatively lower oxidative stress. At 5 microM Cu2+, VLDL and LDL of patients with coronary artery disease still showed a faster oxidation rate, judged by the rate of fluorescence increase, higher TBARS level, less TNBS reactivity, greater change in apo B immunoreactivity and higher electrophoretic mobility than those of normal controls. However, the difference on the oxidizability of HDL was insignificant for patients vs. normals. In conclusion, we have shown that plasma VLDL and LDL of patients with coronary artery disease are more susceptible to in vitro oxidative modification than those of healthy persons. The data suggest that enhanced oxidizability of plasma lipoproteins may be an important factor influencing the development of coronary artery disease. |
| | |
Authors:
|
H C Chiu; J R Jeng; S M Shieh |
Related Documents
:
|
7572679 - The west of scotland coronary prevention study: a trial of cholesterol reduction in sco... 20129369 - Ldl-apheresis in homozygous ldl-receptor-defective familial hypercholesterolemia: the m... 7129689 - Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assesse... 17531569 - Comparison of characteristics of future myocardial infarctions in women with baseline h... 3265059 - Aortic intimal lipid content and serum lipoproteins in patients undergoing coronary by-... 18042049 - Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coro... 19816769 - Calcium binding proteins immunoreactivity in the rat basolateral amygdala following myo... 2248209 - Epidemiologic aspects of heart failure. 10666509 - Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhy... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Biochimica et biophysica acta Volume: 1225 ISSN: 0006-3002 ISO Abbreviation: Biochim. Biophys. Acta Publication Date: 1994 Jan |
Date Detail:
|
Created Date: 1994-02-15 Completed Date: 1994-02-15 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0217513 Medline TA: Biochim Biophys Acta Country: NETHERLANDS |
Other Details:
|
Languages: eng Pagination: 200-8 Citation Subset: IM |
Affiliation:
|
Institute of Biomedical Sciences, Academia Sinica Taipei, Taiwan, ROC. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Apolipoproteins / analysis Copper Coronary Disease / blood* Electrophoresis, Agar Gel Female Humans Lipid Peroxidation Lipoproteins, HDL / blood Lipoproteins, LDL / blood* Lipoproteins, VLDL / blood Male Middle Aged Oxidation-Reduction Spectrometry, Fluorescence Thiobarbituric Acid Reactive Substances / analysis Trinitrobenzenesulfonic Acid |
| Chemical | |
Reg. No./Substance:
|
0/Apolipoproteins; 0/Lipoproteins, HDL; 0/Lipoproteins, LDL; 0/Lipoproteins, VLDL; 0/Thiobarbituric Acid Reactive Substances; 2508-19-2/Trinitrobenzenesulfonic Acid; 7440-50-8/Copper |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats.
Next Document: Effect of liposomally encapsulated MTX-DMPE conjugates upon TNF alpha and PGE2 release by lipopolysa...